Delirium, Dementia, Amnestic, Cognitive Disorders  >>  Oratrope (ibutamoren)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Oratrope (ibutamoren) / Merck (MSD), Lumos Pharma
NCT00074529: Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

Completed
2
512
US
MK0677
Merck Sharp & Dohme LLC
Alzheimer's Disease
01/06
01/06

Download Options